Infections in recipients of liver homografts.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects; D002175:Candida / Q000302:isolation & purification; D003587:Cytomegalovirus / Q000302:isolation & purification; D004755:Enterobacteriaceae / Q000302:isolation & purification; D005260:Female; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007223:Infant; D007239:Infections / Q000209:etiology* / Q000382:microbiology; D008107:Liver Diseases / Q000382:microbiology; D016031:Liver Transplantation; D008297:Male; D009181:Mycoses / Q000097:blood; D011183:Postoperative Complications; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D018805:Sepsis / Q000382:microbiology; D013210:Staphylococcus / Q000302:isolation & purification; D013927:Thrombosis / Q000209:etiology; D014184:Transplantation, Homologous
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D001379:Azathioprine